Welcome to Kingston Oncology Ltd.

Welcome to Kingston Oncology

Kingston Oncology Ltd provides oncology expertise in breast cancer and across a wide range of solid malignancies including from late preclinical to phase IV development. Kingston Oncology Ltd works with both big Pharma and oncology biotech companies

Services.

  • Strategic development plans

  • Protocol development advice (phase I – IV)

  • Support for interaction with regulatory agencies

  • Participation in advisory boards/safety review committees

  • Key opinion leader development

  • Strategic medical monitoring support

Clients.

Kingston Oncology has a wealth of experience with big pharma and biotech including:

Expertise.

  • Key expertise in early and metastatic breast cancer

  • Broad understanding PH-I-IV oncology drug development across major solid tumours

  • Experience with monoclonal antibody, immune oncology and small molecule development

  • Experience across key aspects of drug development; innovative strategy planning, regulatory interactions, protocol development, platform studies, medical affairs support

  • Experience of working broad network of external thought leader contacts and with collaborative groups

Dr Mary Stuart.

Chief Managing Director since 2016

Contact us

If you’d like to get in touch please use the form below.